9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Effect of Physical Activity Coaching on Acute Care and Survival Among Patients With Chronic Obstructive Pulmonary Disease : A Pragmatic Randomized Clinical Trial

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Key Points

          Question

          What is the real-world effectiveness of a 12-month community-based physical activity (PA) coaching intervention on reducing all-cause acute care use and death in patients with a history of a chronic obstructive pulmonary disease (COPD) exacerbation?

          Findings

          In this multisite, randomized clinical trial that included a population-based sample of 2707 patients with COPD, 321 of 1358 patients participated in the PA coaching intervention and increased PA significantly, but there were no significant differences in the all-cause primary outcome (compostite measure of all-cause hospitalizations, observation stays, emergency department visits, and death) at 12 months.

          Meaning

          Most patients with a COPD exacerbation did not engage in PA, and the limited PA did not lead to significant benefit in 12-month health care use.

          Abstract

          This pragmatic randomized clinical trial evaluates the long-term effectiveness of a community-based physical activity coaching intervention on acute care and survival in patients with chronic obstructive pulmonary disease.

          Abstract

          Importance

          While observational studies show that physical inactivity is associated with worse outcomes in chronic obstructive pulmonary disease (COPD), there are no population-based trials to date testing the effectiveness of physical activity (PA) interventions to reduce acute care use or improve survival.

          Objective

          To evaluate the long-term effectiveness of a community-based PA coaching intervention in patients with COPD.

          Design, Setting, and Participants

          Pragmatic randomized clinical trial with preconsent randomization to the 12-month Walk On! (WO) intervention or standard care (SC). Enrollment occurred from July 1, 2015, to July 31, 2017; follow-up ended in July 2018. The setting was Kaiser Permanente Southern California sites. Participants were patients 40 years or older who had any COPD-related acute care use in the previous 12 months; only patients assigned to WO were approached for consent to participate in intervention activities.

          Interventions

          The WO intervention included collaborative monitoring of PA step counts, semiautomated step goal recommendations, individualized reinforcement, and peer/family support. Standard COPD care could include referrals to pulmonary rehabilitation.

          Main Outcomes and Measures

          The primary outcome was a composite binary measure of all-cause hospitalizations, observation stays, emergency department visits, and death using adjusted logistic regression in the 12 months after randomization. Secondary outcomes included self-reported PA, COPD-related acute care use, symptoms, quality of life, and cardiometabolic markers.

          Results

          All 2707 eligible patients (baseline mean [SD] age, 72 [10] years; 53.7% female; 74.3% of white race/ethnicity; and baseline mean [SD] percent forced expiratory volume in the first second of expiration predicted, 61.0 [22.5]) were randomly assigned to WO (n = 1358) or SC (n = 1349). The intent-to-treat analysis showed no differences between WO and SC on the primary all-cause composite outcome (odds ratio [OR], 1.09; 95% CI, 0.92-1.28; P = .33) or in the individual outcomes. Prespecified, as-treated analyses compared outcomes between all SC and 321 WO patients who participated in any intervention activities (23.6% [321 of 1358] uptake). The as-treated, propensity score–weighted model showed nonsignificant positive estimates in favor of WO participants compared with SC on all-cause hospitalizations (OR, 0.84; 95% CI, 0.65-1.10; P = .21) and death (OR, 0.62; 95% CI, 0.35-1.11; P = .11). More WO participants reported engaging in PA compared with SC (47.4% [152 of 321] vs 30.7% [414 of 1349]; P < .001) and had improvements in the Patient-Reported Outcomes Measurement Information System 10 physical health domain at 6 months. There were no group differences in other secondary outcomes.

          Conclusions and Relevance

          Participation in a PA coaching program by patients with a history of COPD exacerbations was insufficient to effect improvements in acute care use or survival in the primary analysis.

          Trial Registration

          ClinicalTrials.gov identifier: NCT02478359

          Related collections

          Most cited references41

          • Record: found
          • Abstract: found
          • Article: not found

          Pulmonary rehabilitation for chronic obstructive pulmonary disease.

          Widespread application of pulmonary rehabilitation (also known as respiratory rehabilitation) in chronic obstructive pulmonary disease (COPD) should be preceded by demonstrable improvements in function (health-related quality of life, functional and maximal exercise capacity) attributable to the programmes. This review updates the review reported in 2006.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            The PRECIS-2 tool: designing trials that are fit for purpose.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              An Official American Thoracic Society/European Respiratory Society Policy Statement: Enhancing Implementation, Use, and Delivery of Pulmonary Rehabilitation.

              Pulmonary rehabilitation (PR) has demonstrated physiological, symptom-reducing, psychosocial, and health economic benefits for patients with chronic respiratory diseases, yet it is underutilized worldwide. Insufficient funding, resources, and reimbursement; lack of healthcare professional, payer, and patient awareness and knowledge; and additional patient-related barriers all contribute to the gap between the knowledge of the science and benefits of PR and the actual delivery of PR services to suitable patients.
                Bookmark

                Author and article information

                Journal
                JAMA Netw Open
                JAMA Netw Open
                JAMA Netw Open
                JAMA Network Open
                American Medical Association
                2574-3805
                16 August 2019
                August 2019
                16 August 2019
                : 2
                : 8
                : e199657
                Affiliations
                [1 ]Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena
                [2 ]Harvard Medical School, Boston, Massachusetts
                [3 ]VA Boston Healthcare System, Boston, Massachusetts
                [4 ]University of Washington, Seattle
                [5 ]VA Puget Sound Health Care System, Seattle, Washington
                [6 ]Kaiser Permanente Southern California, San Diego
                [7 ]Kaiser Permanente Southern California, Orange County, Anaheim
                Author notes
                Article Information
                Accepted for Publication: July 1, 2019.
                Published: August 16, 2019. doi:10.1001/jamanetworkopen.2019.9657
                Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2019 Nguyen HQ et al. JAMA Network Open.
                Corresponding Author: Huong Q. Nguyen, PhD, RN, Department of Research and Evaluation, Kaiser Permanente Southern California, 100 S Los Robles Ave, Second Floor, Pasadena, CA 91101 ( huong.q2.nguyen@ 123456kp.org ).
                Author Contributions: Dr Nguyen had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
                Concept and design: Nguyen, Desai, Towner, Xiang.
                Acquisition, analysis, or interpretation of data: Nguyen, Moy, Liu, Fan, Gould, Desai, Yuen, Lee, Park, Xiang.
                Drafting of the manuscript: Nguyen, Liu, Fan, Towner, Lee, Park.
                Critical revision of the manuscript for important intellectual content: Nguyen, Moy, Liu, Fan, Gould, Desai, Towner, Yuen, Xiang.
                Statistical analysis: Nguyen, Moy, Liu, Lee, Xiang.
                Obtained funding: Nguyen, Xiang.
                Administrative, technical, or material support: Nguyen, Yuen, Park.
                Supervision: Nguyen, Desai, Towner, Xiang.
                Conflict of Interest Disclosures: Dr Nguyen reported receiving grants from the Patient-Centered Outcomes Research Institute (PCORI). Dr Moy reported receiving personal fees from AstraZeneca. Dr Fan reported receiving grants from PCORI, Department of Veterans Affairs, National Institutes of Health, and Firland Foundation. Dr Gould reported receiving grants from PCORI. Dr Towner reported receiving grants from PCORI, Gilead, ViiV Healthcare, and Merck. Dr Xiang reported receiving grants from PCORI. No other disclosures were reported.
                Funding/Support: This work was supported through PCORI award 1403-14117 (Dr Nguyen).
                Role of the Funder/Sponsor: The funding source had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
                Disclaimer: All statements in this report, including its findings and conclusions, are solely those of the authors and do not necessarily represent the views of PCORI, its board of governors, or methodology committee.
                Meeting Presentation: This study was presented at the American Thoracic Society 2019 International Conference; May 20, 2019; Dallas, Texas.
                Data Sharing Statement: See Supplement 3.
                Additional Contributions: We acknowledge our multiple stakeholders who have contributed to the design and implementation of this research study: (1) patient advisory board members (Adrienne Bailey [deceased], Susan Barlett, Reta Coulombe, Kenneth Desjardins [deceased], Ronald Fox [deceased], Gloria Johnson, Freida Miller, Bonnie Tomeoni, and Leslie Paskus), (2) Kaiser Permanente Southern California physical activity coaches (Julie Armstrong, RRT, Erika Britton, Augusto Cam, RRT, Anna DeLeon, Annette Gregson, RRT, Ferdinand Valmonte, Michelle Isom, Sally Leung, Maida Lowery, Edith Medina, Olga Rodriguez, and William Valenson), (3) Kaiser Permanente Southern California pulmonary chiefs (Larry Tom, MD, Cindy Pak, MD, David Suh, MD, Craig Arakaki, MD, Steven Lee, MD, Thomas Mahrer, MD, Michael Markman, MD, Viji Sankar, MD, Nikhil Shah, MD, and George Yuen, MD), (4) Kaiser Permanente Southern California administrators and operational leaders (Jeff Weaver, Shaylynn Buffum, Guillermo Friederichsen, Theodore Fuertes, Hector Garcia, Brian Gardner, Joe Quiroz, Antony Saenz, Jerry Saldana, Steve Cedrone, and Debbie Daclan), and (5) Kaiser Permanente Southern California executive sponsors (Michael Kanter, MD, and Benjamin Broder, MD). We also acknowledge the contributions of our study participants and our data and safety monitoring board members: David Au, MD (University of Washington), Kevin Cain, PhD (University of Washington), and Barbara Sternfeld, PhD (Kaiser Permanente Northern California). The patient advisory board members and the data and safety monitoring board members were compensated for their participation and contributions to the study.
                Article
                zoi190379
                10.1001/jamanetworkopen.2019.9657
                6704745
                31418811
                7d1b671e-c4a8-4824-b672-92db7190c57c
                Copyright 2019 Nguyen HQ et al. JAMA Network Open.

                This is an open access article distributed under the terms of the CC-BY License.

                History
                : 23 January 2019
                : 1 July 2019
                Categories
                Research
                Original Investigation
                Online Only
                Pulmonary Medicine

                Comments

                Comment on this article